Disubstituted phthalazine hedgehog pathway antagonists

Details for Australian Patent Application No. 2010260244 (hide)

Owner Eli Lilly and Company

Inventors Hipskind, Philip Arthur; Patel, Bharvin Kumar; Wilson (nee Takakuwa), Takako

Agent Spruson & Ferguson

Pub. Number AU-A-2010260244

PCT Pub. Number WO2010/147917

Priority 61/218,628 19.06.09 US

Filing date 15 June 2010

Wipo publication date 23 December 2010

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/147917 Priority application(s): WO2010/147917

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010260249-Deuterated i soindolineI, 3-dione derivatives as PDE4 and TNF-alpha inhibitors

2010260234-High eicosapentaenoic acid oils from improved optimized strains of Yarrowia lipolytica